Morgan Stanley
PLSE icon

Morgan Stanley’s Pulse Biosciences PLSE Stock Holding History

Morgan Stanley’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$932K Buy
43,165
+768
+2% +$14.2K ﹤0.01% 5178
2025
Q4 		$582K Buy
42,397
+4,764
+13% +$74.2K ﹤0.01% 5432
2025
Q3 		$666K Sell
37,633
-58,083
-61% -$919K ﹤0.01% 5375
2025
Q2 		$1.44M Buy
95,716
+45,291
+90% +$751K ﹤0.01% 4909
2025
Q1 		$811K Sell
50,425
-11,310
-18% -$211K ﹤0.01% 5106
2024
Q4 		$1.07M Sell
61,735
-8,436
-12% -$149K ﹤0.01% 5052
2024
Q3 		$1.23M Buy
70,171
+30,128
+75% +$514K ﹤0.01% 4924
2024
Q2 		$448K Buy
40,043
+3,059
+8% +$28.8K ﹤0.01% 5335
2024
Q1 		$322K Sell
36,984
-53,892
-59% -$495K ﹤0.01% 5524
2023
Q4 		$1.11M Buy
90,876
+64,482
+244% +$446K ﹤0.01% 5249
2023
Q3 		$106K Sell
26,394
-4,537
-15% -$28.2K ﹤0.01% 5863
2023
Q2 		$222K Buy
30,931
+16,785
+119% +$107K ﹤0.01% 5610
2023
Q1 		$47.5K Sell
14,146
-5,254
-27% -$15.8K ﹤0.01% 6309
2022
Q4 		$53.7K Buy
19,400
+2,364
+14% +$5.31K ﹤0.01% 6256
2022
Q3 		$39K Sell
17,036
-281,593
-94% -$457K ﹤0.01% 6518
2022
Q2 		$457K Buy
298,629
+34,529
+13% +$86.8K ﹤0.01% 5467
2022
Q1 		$1.28M Buy
264,100
+210,781
+395% +$1.73M ﹤0.01% 4824
2021
Q4 		$789K Buy
53,319
+26,346
+98% +$525K ﹤0.01% 5247
2021
Q3 		$583K Sell
26,973
-97,065
-78% -$2.09M ﹤0.01% 5398
2021
Q2 		$2.03M Buy
124,038
+102,566
+478% +$1.95M ﹤0.01% 4619
2021
Q1 		$509K Sell
21,472
-15,001
-41% -$448K ﹤0.01% 5140
2020
Q4 		$870K Buy
36,473
+16,219
+80% +$258K ﹤0.01% 4747
2020
Q3 		$239K Sell
20,254
-4,507
-18% -$48.5K ﹤0.01% 5018
2020
Q2 		$259K Buy
24,761
+3,385
+16% +$30.5K ﹤0.01% 4955
2020
Q1 		$153K Sell
21,376
-14,212
-40% -$147K ﹤0.01% 4990
2019
Q4 		$477K Buy
35,588
+12,851
+57% +$183K ﹤0.01% 4950
2019
Q3 		$351K Buy
22,737
+2,731
+14% +$35.5K ﹤0.01% 4853
2019
Q2 		$264K Sell
20,006
-3,410
-15% -$46.5K ﹤0.01% 4901
2019
Q1 		$412K Sell
23,416
-10,725
-31% -$168K ﹤0.01% 4668
2018
Q4 		$391K Sell
34,141
-319
-0.9% -$3.86K ﹤0.01% 4947
2018
Q3 		$489K Sell
34,460
-1,038
-3% -$14.7K ﹤0.01% 5019
2018
Q2 		$537K Buy
35,498
+1,779
+5% +$30.1K ﹤0.01% 5052
2018
Q1 		$457K Buy
33,719
+3,343
+11% +$63.5K ﹤0.01% 5056
2017
Q4 		$717K Buy
30,376
+13,252
+77% +$313K ﹤0.01% 4762
2017
Q3 		$318K Buy
17,124
+4,017
+31% +$91.2K ﹤0.01% 5134
2017
Q2 		$452K Buy
13,107
+6,367
+94% +$175K ﹤0.01% 4865
2017
Q1 		$138K Buy
+6,740
New +$91.7K ﹤0.01% 5485

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Morgan Stanley's PLSE Position: Q1 2026 in Review

Morgan Stanley increased its Pulse Biosciences (PLSE) stake by 1.8% in Q1 2026, buying an estimated $14.2K and bringing the position to 43,165 shares worth $932K. The position accounts for ﹤0.01% of the portfolio, ranked #5178.

Morgan Stanley first reported a position in PLSE in Q1 2017 and has held it in 37 quarters since. The position peaked at $2.03M in Q2 2021. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Morgan Stanley held 43,165 shares of Pulse Biosciences worth $932K as of Q1 2026.
  • Morgan Stanley bought 768 Pulse Biosciences shares in Q1 2026, an estimated $14.2K.
  • Pulse Biosciences made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5178 holding.
  • Morgan Stanley first reported a position in Pulse Biosciences in Q1 2017 and has held it in 37 quarters since.
  • Morgan Stanley's Pulse Biosciences position peaked at $2.03M in Q2 2021.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.